Garvagliptin is a DPP-4 inhibitor with demonstrated antidiabetic properties. It is used in research to study glucose metabolism and has shown efficacy in both in vitro enzymatic assays and in vivo models of type 2 diabetes.
Molecular Weight:
399.46
CAS Number:
[1601479-87-1]
Formula:
C18H23F2N3O3S
Target:
Others,Proteasome
* VAT and and shipping costs not included. Errors and price changes excepted